Pharma Phorum
JANUARY 17, 2023
Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together with Magnus Jörnten-Karlsson, executive director of Unify.
Bio Pharma Dive
JANUARY 18, 2023
The result from the nearly 4,000-person trial is the latest setback in a long-running effort to develop a safe and effective shot for HIV infections
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JANUARY 20, 2023
Pharmaceutical supply chains are extremely vulnerable to the effects of climate change and face many challenges from sourcing to distribution.
Pharma Times
JANUARY 16, 2023
MHRA approval relates to the company’s midlands-based drug development facilities
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Fierce Pharma
JANUARY 17, 2023
CDC probes possible safety risk for Pfizer's new COVID shot, sees no need to change vaccine practices. zbecker. Tue, 01/17/2023 - 11:49
Bio Pharma Dive
JANUARY 17, 2023
In a conversation at the J.P. Morgan Healthcare conference, the longtime Biogen executive discussed his hesitance to jump back into an executive role and why an opportunity to run Voyager Therapeutics drew him in
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Times
JANUARY 19, 2023
Therapy is among the first to receive a positive draft recommendation under streamlined pilot process
Fierce Pharma
JANUARY 18, 2023
AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets left out. Wed, 01/18/2023 - 14:00
Bio Pharma Dive
JANUARY 19, 2023
“What we’re experiencing now is the aftershock of the party that went on for the last three years,” said Ovid CEO Jeremy Levin in a BioPharma Dive panel that included former Sage head Jeff Jonas and biotech entrepreneur Greg Verdine
Pharmaceutical Technology
JANUARY 16, 2023
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Pharma Times
JANUARY 18, 2023
Therapy is the first oral MET inhibitor treatment option for certain advanced NSCLC adult patients
Fierce Pharma
JANUARY 20, 2023
Ipsen's Onivyde proves its worth in aggressive pancreatic cancer zbecker Fri, 01/20/2023 - 10:48
Bio Pharma Dive
JANUARY 20, 2023
The drugmaker had sought an accelerated approval based on promising data from a small mid-stage trial. Results from a larger study are due in the second quarter
Pharmaceutical Technology
JANUARY 17, 2023
Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia.
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
Pharma Times
JANUARY 18, 2023
Unrelenting pressure caused by strikes, flu and COVID-19 may be keeping NHS in vicious cycle
BioPharma Reporter
JANUARY 17, 2023
In 2022, the UK continued to have a signficant footprint in ATMP clinical research, with total ongoing trials increasing from 168 in 2021 to 178 in 2022, according to a new report. Markets & Regulations
Bio Pharma Dive
JANUARY 20, 2023
Analysts argue the FDA’s choice to decline accelerated approval for donanemab, while surprising, is not the main factor that will determine whether it eventually becomes a commercial success
Pharmaceutical Technology
JANUARY 20, 2023
This week, at the World Economic Forum Annual Meeting, Moderna CEO Stéphane Bancel, said the company plans to build on its exponential growth through the pandemic by expanding its operations globally over the next few years.
Pharma Times
JANUARY 17, 2023
Biosimilar gains MHRA marketing authorisation for use throughout Britain
Fierce Pharma
JANUARY 19, 2023
Bluebird extends cash runway to late 2024 with $113M raise through stock sale esagonowsky Thu, 01/19/2023 - 08:30
Bio Pharma Dive
JANUARY 20, 2023
The regulator’s decision ends a seven-month study pause that followed a report of one participant experiencing mild symptoms of peripheral neuropathy
Pharmaceutical Technology
JANUARY 19, 2023
The US Food and Drug Administration (FDA) has granted Fast Track designation for Avidity Biosciences’ AOC 1020 to treat facioscapulohumeral muscular dystrophy (FSHD).
Pharma Times
JANUARY 16, 2023
Major industry names depart leaving UK pricing deal in serious jeopardy
Fierce Pharma
JANUARY 18, 2023
Servier, Taiho score in phase 3 colorectal cancer trial to support Lonsurf combo nod. kdunleavy. Wed, 01/18/2023 - 15:13
Bio Pharma Dive
JANUARY 20, 2023
The China-based drugmaker hopes Brukinsa’s survival data will help its drug compete with Imbruvica and Calquence
Pharmaceutical Technology
JANUARY 16, 2023
While the threat of high inflation is receding, its second-round effects may not quickly abate. Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023.
Pharma Times
JANUARY 20, 2023
The NICE recommendation followed data from clinical trials and real-world evidence
Fierce Pharma
JANUARY 20, 2023
Martin Shkreli runs afoul of FTC for potentially skirting lifetime pharmaceutical industry ban fkansteiner Fri, 01/20/2023 - 15:34
Bio Pharma Dive
JANUARY 17, 2023
Elicio’s combination with Angion Biomedica comes months after it abandoned a new stock offering, and is the latest example of how the IPO slowdown has shifted startups’ plans
Pharmaceutical Technology
JANUARY 19, 2023
Sun Pharmaceutical Industries has signed a definitive agreement to buy all outstanding shares of Concert Pharmaceuticals, in a deal valued at $576m. Under the deal terms, the company will buy all shares of Concert common stock through a tender offer for $8.00 per share in cash upfront payment.
Pharma Times
JANUARY 19, 2023
The new funding package will be used to progress NeoPhore’s expanding pipeline of therapies
Fierce Pharma
JANUARY 19, 2023
Fierce Pharma Asia—China's reimbursement round; Sun's alopecia bet; GenScript's CDMO raise aliu Thu, 01/19/2023 - 15:53
Bio Pharma Dive
JANUARY 19, 2023
Shoreline will acquire a preclinical NK cell therapy Editas has been developing, as well as a license to use the CRISPR biotech’s gene editing technology
Pharmaceutical Technology
JANUARY 19, 2023
The Korean Ministry of Food and Drug Safety (KMFDS) has granted expanded approval to Novavax partner SK bioscience for the Covid-19 vaccine, Nuvaxovid (NVX-CoV2373), for use as a booster dose in adults aged 18 and above.
Expert insights. Personalized for you.
83 
Let's personalize your content